132 related articles for article (PubMed ID: 11172682)
1. Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3).
Lokeshwar BL; Escatel E; Zhu B
Curr Med Chem; 2001 Feb; 8(3):271-9. PubMed ID: 11172682
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model.
Lokeshwar BL; Selzer MG; Zhu BQ; Block NL; Golub LM
Int J Cancer; 2002 Mar; 98(2):297-309. PubMed ID: 11857423
[TBL] [Abstract][Full Text] [Related]
3. Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines.
Tolomeo M; Grimaudo S; Milano S; La Rosa M; Ferlazzo V; Di Bella G; Barbera C; Simoni D; D'Agostino P; Cillari E
Br J Pharmacol; 2001 May; 133(2):306-14. PubMed ID: 11350867
[TBL] [Abstract][Full Text] [Related]
4. MMP inhibition in prostate cancer.
Lokeshwar BL
Ann N Y Acad Sci; 1999 Jun; 878():271-89. PubMed ID: 10415736
[TBL] [Abstract][Full Text] [Related]
5. Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers.
Lokeshwar BL
Pharmacol Res; 2011 Feb; 63(2):146-50. PubMed ID: 21093590
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor cell invasiveness by chemically modified tetracyclines.
Gu Y; Lee HM; Roemer EJ; Musacchia L; Golub LM; Simon SR
Curr Med Chem; 2001 Feb; 8(3):261-70. PubMed ID: 11172681
[TBL] [Abstract][Full Text] [Related]
7. Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells.
Meng Q; Xu J; Goldberg ID; Rosen EM; Greenwald RA; Fan S
Clin Exp Metastasis; 2000; 18(2):139-46. PubMed ID: 11235989
[TBL] [Abstract][Full Text] [Related]
8. Chemically modified tetracyclines induce apoptosis in cultured mast cells.
Sandler C; Nurmi K; Lindstedt KA; Sorsa T; Golub LM; Kovanen PT; Eklund KK
Int Immunopharmacol; 2005 Oct; 5(11):1611-21. PubMed ID: 16039551
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory impacts of chemically modified tetracycline-3 and underlying mechanism in human cervical cancer cells.
Zhao L; Xu J; Yang Y; Chong Y; Liu C; Jiao Y; Fan S
Anticancer Drugs; 2013 Sep; 24(8):799-809. PubMed ID: 23722439
[TBL] [Abstract][Full Text] [Related]
10. Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells.
Onoda T; Ono T; Dhar DK; Yamanoi A; Nagasue N
Int J Cancer; 2006 Mar; 118(5):1309-15. PubMed ID: 16152604
[TBL] [Abstract][Full Text] [Related]
11. Chemically modified tetracyclines induce cytotoxic effects against J774 tumour cell line by activating the apoptotic pathway.
D'Agostino P; Ferlazzo V; Milano S; La Rosa M; Di Bella G; Caruso R; Barbera C; Grimaudo S; Tolomeo M; Feo S; Cillari E
Int Immunopharmacol; 2003 Jan; 3(1):63-73. PubMed ID: 12538035
[TBL] [Abstract][Full Text] [Related]
12. Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.
Lokeshwar BL; Houston-Clark HL; Selzer MG; Block NL; Golub LM
Adv Dent Res; 1998 Nov; 12(2):97-102. PubMed ID: 9972130
[No Abstract] [Full Text] [Related]
13. CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer.
Lee HM; Golub LM; Cao J; Teronen O; Laitinen M; Salo T; Zucker S; Sorsa T
Curr Med Chem; 2001 Feb; 8(3):257-60. PubMed ID: 11172680
[TBL] [Abstract][Full Text] [Related]
14. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.
Seftor RE; Seftor EA; De Larco JE; Kleiner DE; Leferson J; Stetler-Stevenson WG; McNamara TF; Golub LM; Hendrix MJ
Clin Exp Metastasis; 1998 Apr; 16(3):217-25. PubMed ID: 9568639
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
[TBL] [Abstract][Full Text] [Related]
16. Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors.
Holmes SG; Still K; Buttle DJ; Bishop NJ; Grabowski PS
Bone; 2004 Aug; 35(2):471-8. PubMed ID: 15268899
[TBL] [Abstract][Full Text] [Related]
17. Role of Chemically Modified Tetracyclines in the Management of Periodontal Diseases: A Review.
Ghangurde AA; Ganji KK; Bhongade ML; Sehdev B
Drug Res (Stuttg); 2017 May; 67(5):258-265. PubMed ID: 28268238
[TBL] [Abstract][Full Text] [Related]
18. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells.
Song H; Fares M; Maguire KR; Sidén A; Potácová Z
PLoS One; 2014; 9(12):e114457. PubMed ID: 25502932
[TBL] [Abstract][Full Text] [Related]
20. Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells.
Bettany JT; Wolowacz RG
Adv Dent Res; 1998 Nov; 12(2):136-43. PubMed ID: 9972138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
